Longeveron (LGVN) Accumulated Expenses (2021 - 2026)

Longeveron (LGVN) recorded quarterly Accumulated Expenses of $2.9 million in Q1 2026, down 1.62% quarter-over-quarter from $3.0 million in Q4 2025, and up 77.35% on a YoY basis from $1.6 million in Q1 2025.

Longeveron (LGVN) Accumulated Expenses (2021 - 2026) Analysis & Trends

Longeveron's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $2.9 million for Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 77.35% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 77.35% YoY), while the FY2025 annual figure was $3.0 million, up 63.13% from the prior year.
  • Accumulated Expenses was $2.9 million for Q1 2026 at Longeveron, down from $3.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.2 million in Q3 2025 to a low of $613000.0 in Q1 2023.
  • Historically, Accumulated Expenses has averaged $1.9 million across 5 years, with a median of $1.7 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Accumulated Expenses plunged 51.02% in 2022, then jumped 291.68% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $650000.0 in 2022, then surged by 231.08% to $2.2 million in 2023, then retreated by 15.43% to $1.8 million in 2024, then soared by 63.13% to $3.0 million in 2025, then decreased by 1.62% to $2.9 million in 2026.
  • The last three Accumulated Expenses figures came in at $2.9 million (Q1 2026), $3.0 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2.92 Mn
Dec 31, 2025 2.97 Mn
Sep 30, 2025 3.17 Mn
Jun 30, 2025 1.91 Mn
Mar 31, 2025 1.65 Mn
Dec 31, 2024 1.82 Mn
Sep 30, 2024 1.48 Mn
Jun 30, 2024 1.61 Mn
Mar 31, 2024 2.40 Mn
Dec 31, 2023 2.15 Mn
Sep 30, 2023 1.47 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 613,000.00
Dec 31, 2022 650,000.00
Dec 31, 2021 1.33 Mn